Clinical Trial News and Research

RSS

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making it more accessible and efficient.

16 Apr 2025

Early combination treatment can prevent heart attacks and save lives

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

16 Apr 2025

Blood test for tumor DNA may predict melanoma recurrence

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

15 Apr 2025

Mid afternoon inhaler use may improve nighttime asthma control

A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken mid afternoon, may be the best timing for effective asthma control as it suppresses the usual nocturnal worsening of symptoms more effectively than dosing regimens at other times of the day, suggest the results of a small clinical trial published in the journal Thorax.

15 Apr 2025

Peanuts pack a punch for youth: study finds cellular benefits

Daily consumption of skin-roasted peanuts for six months led to a modest but significant increase in telomere length among young, healthy adults, while peanut butter did not show this effect.

15 Apr 2025

Afternoon could be best time for asthma inhaler, study shows

A mid-afternoon puff could be the best way to get the most out of your asthma inhaler according to a new study led by University of Manchester researchers.

15 Apr 2025

Early combination therapy after heart attack reduces risk of recurrence and death

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.

14 Apr 2025

Weight-loss lifestyle changes slow bone loss in older adults

Researchers evaluate the effects of a weight-loss lifestyle intervention on age-related bone deterioration.

14 Apr 2025

RSV-associated infections linked to higher one year mortality in adults

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death within one year compared to the general population.

11 Apr 2025

Boosting tumor-infiltrating lymphocyte therapy with the power of B cells

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL therapy.

11 Apr 2025

New guidelines released for managing hypercholesterolemia in adults over 75

The National Lipid Association (NLA) and the American Geriatrics Society (AGS) have released a Joint Scientific Statement focused on the management of hypercholesterolemia in adults older than 75 years who do not have a history of atherosclerotic cardiovascular disease (ASCVD).

10 Apr 2025

Coaxial silicone drains reduce pain after VATS lobectomy without compromising efficacy

Chest drains are routinely used after video-assisted thoracoscopic surgery (VATS) lung resections to evacuate fluid and air from the pleural space.

10 Apr 2025

New liver directed treatment improves outcomes for rare eye cancer

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver.

10 Apr 2025

Source Bioscience acquires Cambridge Clinical Laboratories

Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a leading Cambridge-based provider of clinical, personalized healthcare testing services.

10 Apr 2025

Mindfulness and cognitive behavioral therapies offer lasting relief for chronic low back pain

Researchers compare the long-term effectiveness of mindfulness and CBT among adults with opioid-treated chronic low back pain.

10 Apr 2025

Study shows wisdom of early US investment in COVID-19 vaccines

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new pandemic surged around them. By a year later, 66 million American adults had gotten at least one dose of a COVID-19 vaccine, at no cost to them. Now, a new study shows how wise that national investment in testing, buying and delivering the first vaccines was.

10 Apr 2025

Sylvester Cancer Center launches clinical trial for patients with high-grade neuroendocrine tumors

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

9 Apr 2025

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions.

9 Apr 2025

Oklahoma Children's Hospital improves care for babies with neonatal abstinence syndrome

In years past, health care providers took a punitive stance toward women giving birth to babies exposed to substances like opioids in the womb.

9 Apr 2025

Mirvie reveals new advances in the biological understanding of hypertensive disorders of pregnancy

Today, Mirvie announced results of a breakthrough study published in Nature Communications, revealing new advances in the biological understanding of hypertensive disorders of pregnancy (HDP), including preeclampsia - a leading cause of maternal morbidity and mortality as well as preterm birth.

9 Apr 2025